n-hydroxysuccinimide has been researched along with Cardiovascular Stroke in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alarcon, EI; Cron, G; Goel, K; Hosoyama, K; Liang, W; McLaughlin, S; McNeill, B; Podrebarac, J; Rayner, KJ; Ruel, M; Sedlakova, V; Seymour, R; Smyth, D; Suuronen, EJ | 1 |
Abraham, MR; Abraham, TP; Armstrong, PA; Brown, SN; Chan, AT; Chang, CY; Elisseeff, JH; Higuchi, T; Lin, X; Luo, HC; O'Rourke, B; Steenbergen, CJ; Strehin, IA; Vakrou, S; Wahl, RL | 1 |
Battaglia, TM; Beaudoin, S; Booksh, KS; Khairallah, P; Masson, JF | 1 |
3 other study(ies) available for n-hydroxysuccinimide and Cardiovascular Stroke
Article | Year |
---|---|
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction.
Topics: Animals; Capillaries; Carbodiimides; Cell Proliferation; Cell Survival; Cicatrix; Collagen Type I; Collagen Type III; Coronary Vessels; Cross-Linking Reagents; Dimethylamines; Heart; Humans; Macrophages; Mice; Monocytes; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Recombinant Proteins; Succinimides; Ventricular Function; Ventricular Remodeling | 2019 |
Hyaluronic acid-human blood hydrogels for stem cell transplantation.
Topics: Animals; Blood Cells; Cell Proliferation; Cell Survival; Cells, Cultured; Elastic Modulus; Female; Humans; Hyaluronic Acid; Hydrogels; Male; Myocardial Infarction; Myocardium; Plasma; Rats; Rats, Inbred WKY; Rats, Nude; Stem Cell Transplantation; Succinimides; Tissue Scaffolds | 2012 |
Quantitative measurement of cardiac markers in undiluted serum.
Topics: Antibodies; Antigens; Biomarkers; Calibration; Humans; Myocardial Infarction; Myoglobin; Palmitic Acids; Sensitivity and Specificity; Succinimides; Surface Plasmon Resonance; Troponin | 2007 |